Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes?

被引：21

作者：

Brereton, Christopher J. ^{[1
,2
]}

Wallis, Timothy ^{[1
]}

Casey, Michelle ^{[3
]}

Fox, Lynn ^{[3
]}

Pontopiddan, Katarina ^{[1
]}

Laws, Diane ^{[4
]}

Graves, Jennifer ^{[5
]}

Titmuss, Vanessa ^{[6
]}

Kearney, Sarah ^{[7
]}

Evans, Sian ^{[8
]}

Grove, Alison ^{[9
]}

Hamid, Samreen ^{[10
]}

Richeldi, Luca ^{[11
]}

O'Reilly, Katherine M. A. ^{[3
,12
]}

Fletcher, Sophie V. ^{[1
]}

Jones, Mark G. ^{[1
,2
]}

机构：

[1] Univ Hosp Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England

[2] Univ Southampton, Clin Expt Sci, Southampton, Hants, England

[3] Mater Misericordiae Univ Hosp, Dublin, Ireland

[4] Royal Bournemouth & Christchurch Hosp NHS Fdn Tru, Bournemouth, Dorset, England

[5] Dorset Cty Hosp NHS Fdn Trust, Dorchester, England

[6] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England

[7] Isle Wight NHS Trust, Newport, Shrops, England

[8] Salisbury NHS Fdn Trust, Salisbury, Wilts, England

[9] Hampshire Hosp NHS Fdn Trust, Winchester, Hants, England

[10] Poole Hosp NHS Fdn Trust, Poole, Dorset, England

[11] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Rome, Italy

[12] Univ Coll Dublin, Sch Med, Dublin, Ireland

来源：

ERJ OPEN RESEARCH | 2020年 / 6卷 / 02期

关键词：

D O I：

10.1183/23120541.00120-2020

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 8 条

[1] Risk factors for diagnostic delay in idiopathic pulmonary fibrosis
Hoyer, Nils
Prior, Thomas Skovhus
Bendstrup, Elisabeth
Wilcke, Torgny
Shaker, Saher Burhan
[J]. RESPIRATORY RESEARCH, 2019, 20 (1):
[2] Delayed Access and Survival in Idiopathic Pulmonary Fibrosis A Cohort Study
Lamas, Daniela J.
Kawut, Steven M.
Bagiella, Emilia
Philip, Nisha
Arcasoy, Selim M.
Lederer, David J.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (07) : 842 - 847
[3] Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Maher, Toby M.
Strek, Mary E.
[J]. RESPIRATORY RESEARCH, 2019, 20 (01)
[4] Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views
Maher, Toby M.
Swigris, Jeffrey J.
Kreuter, Michael
Wijsenbeek, Marlies
Cassidy, Nicola
Ireland, Lucy
Axmann, Judit
Nathan, Steven D.
[J]. RESPIRATION, 2018, 96 (06) : 514 - 524
[5] Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries
Mooney, Joshua
Chang, Eunice
Lalla, Deepa
Papoyan, Elya
Raimundo, Karina
Reddy, Sheila R.
Stauffer, John
Yan, Tingjian
Broder, Michael S.
[J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (03) : 393 - 396
[6] Purokivi M, 2017, EUR CLIN RESPIR J, V4, DOI 10.1080/20018525.2017.1290339
[7] Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence
Richeldi, Luca
Varone, Francesco
Bergna, Miguel
de Andrade, Joao
Falk, Jeremy
Hallowell, Robert
Jouneau, Stephane
Kondoh, Yasuhiro
Morrow, Lee
Randerath, Winfried
Strek, Mary
Tabaj, Gabriela
[J]. EUROPEAN RESPIRATORY REVIEW, 2018, 27 (150)
[8] Towards a better diagnosis of idiopathic pulmonary fibrosis
Valeyre, D.
[J]. EUROPEAN RESPIRATORY REVIEW, 2011, 20 (120) : 108 - 113

← 1 →